| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PNRC2 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | TMEM106A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | DIXDC1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | STK33 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | ROGDI | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ZNF334 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | ETAA1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | DGKA | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BASP1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | EPS8L2 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.09 |
